|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Trade, net of allowance of $411,806 and $1,327,808, respectively | ||||||||||||||||||||
| Other receivables | ||||||||||||||||||||
| Notes receivable | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Capitalized production costs, net | ||||||||||||||||||||
| Right-of-use asset | ||||||||||||||||||||
| Employee receivable | ||||||||||||||||||||
| Right-of-use assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Total | ||||||||||||||||||||
| Property, equipment and leasehold improvements, net | ||||||||||||||||||||
| Other long-term assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Term loans, current portion | ||||||||||||||||||||
| Revolving line of credit | ||||||||||||||||||||
| Contingent consideration | ||||||||||||||||||||
| Notes payable, current portion | ||||||||||||||||||||
| Convertible notes payable, current portion | ||||||||||||||||||||
| Accrued interest – related party | ||||||||||||||||||||
| Accrued compensation – related party | ||||||||||||||||||||
| Lease liability, current portion | ||||||||||||||||||||
| Lease liabilities, current portion | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Revolving line of credit, noncurrent portion | ||||||||||||||||||||
| Term loans, noncurrent portion | ||||||||||||||||||||
| Notes payable, noncurrent portion | ||||||||||||||||||||
| Convertible notes payable | ||||||||||||||||||||
| Convertible notes payable– related party | ||||||||||||||||||||
| Convertible notes payable – related party | ||||||||||||||||||||
| Convertible note payable at fair value | ||||||||||||||||||||
| Lease liability | ||||||||||||||||||||
| Loans from related party | ||||||||||||||||||||
| Lease liabilities | ||||||||||||||||||||
| Deferred tax liability | ||||||||||||||||||||
| Warrant liability | ||||||||||||||||||||
| Other noncurrent liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Preferred Stock, Series C, $0.001 par value, 50,000 shares authorized, 50,000 shares issued and outstanding at June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Common stock, $0.015 par value, 200,000,000 shares authorized, 13,025,551 and 12,221,432 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total Stockholders’ Equity | ||||||||||||||||||||
| Total Liabilities and Stockholders’ Equity | ||||||||||||||||||||
Loading...
